InvestorsHub Logo
Followers 43
Posts 2842
Boards Moderated 0
Alias Born 07/08/2003

Re: jakedogman1 post# 277059

Monday, 10/24/2016 11:11:39 AM

Monday, October 24, 2016 11:11:39 AM

Post# of 346385
Jake, At the ASM Q&A King was asked is we were talking with Merk and he succinctly answered, "Yes."

SK appears w/ Merck

9-22-16 9:50-10:20am Panel:
“Analyzing The Business & Partnering Model In Industry & Academia For The Future Development Of Immuno-Oncology Combination Therapies”
Panelists/Speakers:
* Donnie McGrath - VP, Head Search & Evaluation, BusDev, Bristol-Myers Squibb
* Emmett Schmidt = Exec.Dir., Clinical Research, Merck Sharp & Dohme
* Jennifer Buell VP, Development Operations, Agenus
* Steven King – Pres. & CEO, Peregrine Pharmaceuticals


We know the facts so your FUD (Fear Uncertainty and Doubt) is useless here.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News